INSIGHTS
View all →
Insights

Peter Attia Steps Down From David Protein After Epstein

Published Feb 5, 2026
Updated Apr 30, 2026
Peter Attia Steps Down From David Protein After Epstein

Longevity Guru Peter Attia Departs David Protein Amid Controversy

Dr. Peter Attia, a prominent figure in longevity and preventive health, has stepped down from his role as Chief Science Officer at David Protein, a company known for its high-protein nutrition bars. The announcement was made on social media platform X.

This development follows the public release of over 1,700 documents connected to convicted sex offender Jeffrey Epstein. Attia's name appeared in email correspondence within these files. He had served on the executive team and was an early investor in the nutrition startup. David Protein, founded three years ago, had recently secured a significant $75 million Series A funding round. The company's flagship protein bar, launched in September 2024, boasts 28 grams of protein, zero sugar, and 150 calories.

Attia addressed the situation in a lengthy post on X, expressing shame over the nature of some of his emails with Epstein. However, he stated that he was not involved in any criminal activities, nor did he visit Epstein's island or travel on his plane. Attia also elaborated on how he initially met Epstein and his reasons for remaining involved even after Epstein's 2008 conviction.

Potential Fallout for Biograph Startup

The repercussions of this situation may extend beyond David Protein. Biograph, a healthcare testing and longevity startup co-founded by Attia and entrepreneur John Hering, also appears to be distancing itself from the physician. When contacted for comment, Biograph declined to discuss Attia's continued involvement or the changes on its website. Previously, Attia was prominently featured on the company's press releases and website as a co-founder. However, mentions of him have since been removed, or corresponding pages now result in a "file not found" error.

Biograph, which emerged from stealth a year ago, offers premium preventive health services to subscribers paying between $7,500 and $15,000 annually. The company had secured backing from notable investors and angel investors, including Balaji Srinivasan.

At Devignitor Insights, we observe how public figures navigate challenging situations that impact their professional affiliations and business ventures. This case highlights the scrutiny that individuals in the public eye face, particularly when their associations come under review.

Found this helpful? Share it.

You May Also Like

Masha Bucher Addresses Epstein Link, Offers Explanation

https://devignitor.com/insights/masha-bucher-addresses-jeffrey-epstein-association-offers-explanation
Tech News

FBI Informant Reveals Epstein’s Personal Hacker Ties

https://devignitor.com/insights/fbi-informant-detailed-epsteins-alleged-ties-to-a-personal-hacker-court-documents-show
Tech News

Billionaires Rethink Giving Pledge, A Decade Later

https://devignitor.com/insights/billionaires-rethink-giving-pledge-a-decade-later
Tech News

xAI Loses Co-Founders and Senior Engineers Amid Controversy

https://devignitor.com/insights/xai-loses-co-founders-and-senior-engineers-amidst-controversy
Tech News

Bill Gurley Advice, Don't Play it Safe in Your Career

https://devignitor.com/insights/bill-gurley-advice-dont-play-it-safe-in-your-career
Tech News